Dr. Basu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Fl 5
Philadelphia, PA 19104Phone+1 215-662-2777
Summary
- I see patients at the Hospital of the University of Pennsylvania, where I am an Associate Professor with 11 years of experience as an oncologic and reconstructive surgeon. I use open, endoscopic, robotic, and laser procedures to treat neoplasms of the larynx, pharynx, oral cavity, nasal cavity, paranasal sinuses, salivary glands, parapharyngeal space, and skin. I am also experienced in thyroid and parathyroid surgery.
My research group focuses on squamous cell carcinomas of the head and neck, with emphasis on the rapidly growing HPV+ subtype of this disease. This NIH-funded work seeks to address show cancers evade therapy by exploiting aspects of normal human development and devises strategies to improve drug responses by modulating the developmental plasticity inherent in malignant cells. In doing so, our goals are to increase survival for the worst head and neck cancers and alter management for readily curable ones in order to abate treatment toxicity. My dual clinical and scientific roles drive optimal research use of resected cancers to serve these long-term goals.
Education & Training
- The Wistar InstitutePost-Doctoral Fellowship, 2007 - 2012
- University of Pennsylvania Health SystemFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2006 - 2007
- Washington University/B-JH/SLCH ConsortiumResidency, Otolaryngology - Head and Neck Surgery, 2002 - 2006
- Washington University/B-JH/SLCH ConsortiumInternship, Otolaryngology - Head and Neck Surgery, 2001 - 2002
- Washington University in St. Louis School of MedicineClass of 2001
- Washington University in St. LouisPh.D., Immunology, 2001
- Brown UniversitySc.B., Biology, magna cum laude, 1990 - 1994
- Brown UniversityBS, Biology, Magna Cum Laude, 1994
Certifications & Licensure
- MO State Medical License 2004 - 2025
- PA State Medical License 2006 - 2024
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Member American Head and Neck Society
- Fellow Triological Society
- Member American Association for Cancer Research
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- The imprint of viral oncoproteins on the variable clinical behavior among human papilloma virus-related oropharyngeal squamous cell carcinomas.Malay K Sannigrahi, Lovely Raghav, Ahmed Diab, Devraj Basu
Tumour Virus Research. 2024-12-01 - 1 citationsHPV16 genome structure analysis in oropharyngeal cancer PDXs identifies tumors with integrated and episomal genomes.Claire D James, Raymonde O Otoa, Aya H Youssef, Christian T Fontan, Malay K Sannigrahi
Tumour Virus Research. 2024-12-01 - Association of oropharyngeal cancer recurrence with tumor-intrinsic and immune-mediated sequelae of reduced genomic instability.Malay K Sannigrahi, Lovely Raghav, Dominick J Rich, Travis P Schrank, Joseph A Califano
Biorxiv. 2024-11-04
Journal Articles
- Shear Wave Elastography in the Evaluation of Thyroid Nodules and Correlation with Aggressive Features on Microscopy: A Case ReportChen DW,1 Horst J, Basu D, Dalal S, Jhala D, Hyland KA, Consultant360, 1/1/2018
- IL-6 mediates cross-talk between activated fibroblasts and tumor cells in the tumor microenvironmentKarakasheva TA, Lin EW, Tang Q, Qiao E, Waldron TJ, Soni M, Klein-Szanto AJ, Sahu V, Basu D, Ohashi S, Baba K, Giaccone ZT, Walker SR, Frank DA, Wileyto EP, Long Q, Du..., Cancer Research, 1/1/2018
- IL-6 Mediates Cross-Talk Between Activated Fibroblasts and Tumor Cells in the Tumor MicroenvironmentDevraj Basu, Eric W Lin, Clinical Cancer Research
- Join now to see all
Books/Book Chapters
Lectures
- Identifying adverse molecular features of HPV+ head and neck cancers using patient-derived models.2019 ASCO Annual Meeting - 6/1/2019
- Leveraging patient-derived models of HPV+ head and neck cancerVirginia Commonwealth University School of Dentistry, Richmond, VA - 1/1/2018
- Genetic Determinants of PDX Growth in HPV+ Head and Neck CancerScottsdale, AZ - 1/1/2018
- Join now to see all
Other
- Basu D, Truelson JM, Weinstein GSeMedicine
http://emedicine.medscape.com/article/850738-overview
1/1/2014
Press Mentions
- Recipients of AACR Research Funding & Fellowships 1993–2017September 8th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: